SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #6,327CAS 3区Hybrid

European Journal of Pharmaceutics and Biopharmaceutics

Abbreviation (ISO):EUR. J. PHARM. BIOPHARM
Country: Netherlands•WoS SCIE Quartile: Q1•Scopus SJR: 0.848•SCImago Rank: #6,327•Identifier (ISSN):0939-6411(Print)/1873-3441(Online)•Articles / Year: 235•Estimated Publication Fee (APC): $3,234 USD
Clarivate IF (2026)Q1
5
↑ +0.7

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
138

138 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.3%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
235articles/year
34.91% Gold OA•95.11% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 5)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 5)
🔵 Computed
20252.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.3)
🔵 Computed
20242.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.4)
🔵 Computed
20232.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.9)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.589)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 5.571)
🔵 Computed
20202.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.604)
🔵 Computed
20192.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.708)
🔵 Computed
20182.50đ
WoS Q1 có IF ≥ 3.0(IF: 4.491)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics. Topics covered include for example: Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids) Aspects of manufacturing process design Biomedical aspects of drug product design Strategies and formulations for controlled drug transport across biological barriers Physicochemical aspects of drug product development Novel excipients for drug product design Drug delivery and controlled release systems for systemic and local applications Nanomaterials for therapeutic and diagnostic purposes Advanced therapy medicinal products Medical devices supporting a distinct pharmacological effect.

Topics Covered (Recognized by AI)
ChemistryBiologyMedicineOrganic ChemistryMaterials SciencePhysicsEngineeringBiochemistryPharmacologyChemical EngineeringGeneticsChromatographyNanotechnologyComposite MaterialsInternal MedicineQuantum MechanicsPsychologyPhysical ChemistryNuclear Magnetic ResonanceBioinformaticsPsychiatryGeology
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #6,327Scopus Q1SCImago Profile
Scopus Coverage:1991-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
0.848

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
201

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
5.26

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,234 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations4,093
3-Year Documents783
Citable Documents771

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.8%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Pharmaceutical ScienceQ1
BiotechnologyQ2
Medicine (miscellaneous)Q2

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
7.5周
Average time to first editorial decision
Online Publication Speed
4.1周
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Elsevier
Publication Language
English
Frequency
Bimonthly
Founding Year
1991
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
70/356Q1
PHARMACOLOGY & PHARMACY
JCISCIE
50/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—19786
20254.3272955
20244.43413,345
20234.92603,889
20225.5892374,261
20215.5712266,368
20204.6042999,051
20194.70826610,436
20184.49132913,535
2017—30313,055
2016—33316,324
2015—33821,361
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for European Journal of Pharmaceutics and Biopharmaceutics

WoS Q1
3467201820192020202120222023202420254.30
Annual Impact Factor Metric
2025:4.3

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.3%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 36551ca1-297a-45a3-9374-b7858e71bc51
Database Updated: 2026-09-28